Beta Wealth Group’s Bristol-Myers Squibb BMY Stock Holding History

Beta Wealth Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-7,111	Closed	-$295K	–	107
2024 Q2	$295K	Buy	7,111 +799	+13%	+$35.8K	0.14%	86
2024 Q1	$342K	Buy	6,312 +88	+1%	+$4.48K	0.17%	85
2023 Q4	$319K	Buy	6,224 +22	+0.4%	+$1.16K	0.17%	85
2023 Q3	$360K	Buy	6,202 +202	+3%	+$12.4K	0.21%	79
2023 Q2	$384K	Buy	6,000 +1,100	+22%	+$73.8K	0.22%	74
2023 Q1	$340K	Buy	4,900 +400	+9%	+$28.2K	0.19%	78
2022 Q4	$324K	Buy	+4,500	New	+$339K	0.22%	77

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Beta Wealth Group's BMY Position: Q3 2024 in Review

Beta Wealth Group sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 7,111 shares — an estimated $295K sold.

Beta Wealth Group first reported a position in BMY in Q4 2022 and held it in 7 quarters. The position peaked at $384K in Q2 2023. 2,263 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

Beta Wealth Group reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
Beta Wealth Group sold 7,111 Bristol-Myers Squibb shares in Q3 2024, an estimated $295K.
Beta Wealth Group first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 7 quarters.
Beta Wealth Group's Bristol-Myers Squibb position peaked at $384K in Q2 2023.
2,263 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Beta Wealth Group's 13F filing for Q3 2024, filed 1 Nov 2024.